<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01400724</url>
  </required_header>
  <id_info>
    <org_study_id>INOFOLIC-NRT</org_study_id>
    <secondary_id>NRT-LO.LI</secondary_id>
    <nct_id>NCT01400724</nct_id>
  </id_info>
  <brief_title>Inofolic NRT and the Metabolic Syndrome</brief_title>
  <official_title>Effects of Inofolic NRT on Post-menopausal Women Affected by the Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomized, controlled, open-label study will be carried out on 80
      post-menopausal women affected by the metabolic syndrome (criteria are described in NIH ATP
      III). After a written informed consent, women will be randomly treated for 6 months with
      hypocaloric diet (control group) or with diet and a supplementation of myo-inositol 2000 mg
      plus cocoa polyphenols 30 mg and plus isoflavones 80 mg. will be given randomly Eighty
      post-menopausal women, affected by metabolic syndrome will be randomized into two groups: 40
      treated with myo-inositol 2 g twice per day and forty treated with placebo for six months.
      The investigators hypothesize that the administration of myo-inositol would improve the
      insulin-receptor activity in these women, reducing insulin resistance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria: post-menopausal women (12 months after last menstruation) affected by
      metabolic syndrome according to ATP III, 2001.

      At least 3 of following 5 criteria must be present:

        1. waist circumference &gt; 88 cm

        2. Triglycerides &gt; 150 mg/dl

        3. HDL-cholesterol &lt; 50 mg/dl

        4. Fast glycemia &gt; 110 mg/dl

        5. Systolic blood pressure &gt; 135 mmHg. diastolic &gt; 85 mmHg -

      Exclusion Criteria:1) post-menopausal women with less than 12 months from the last
      menstruation 2) less than 3 criteria according with ATP III 3) TSH &gt; 3.5 4) in treatment with
      drugs lowering glycemia or cholesterol 5) allergy to cocoa
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage reduction of women with metabolic syndrome</measure>
    <time_frame>at baseline and after 6 months.</time_frame>
    <description>evaluation of metabolic syndrome criteria according with ATP III 2001</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of insulin resistance</measure>
    <time_frame>at baseline and after 6 months</time_frame>
    <description>evaluation of HOMA-IR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of lipid profile</measure>
    <time_frame>at baseline and after 6 months</time_frame>
    <description>reduction of serum triglycerides and increase of HDL-cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>variation in serum concentration of adiponectin, visfatin and resistin</measure>
    <time_frame>at baseline and after 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Postmenopausal Disorder</condition>
  <arm_group>
    <arm_group_label>Inofolic NRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inofolic NRT</intervention_name>
    <description>Dietary supplement: myo-inositol 2000 mg plus cocoa polyphenols 30 mg and plus isoflavones 80 mg</description>
    <arm_group_label>Inofolic NRT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: post-menopausal women (12 months after last menstruation) affected by
        metabolic syndrome according to ATP III, 2001.

        At least 3 of following 5 criteria must be present:

          1. waist circumference &gt; 88 cm

          2. Triglycerides &gt; 150 mg/dl

          3. HDL-cholesterol &lt; 50 mg/dl

          4. Fast glycemia &gt; 110 mg/dl

          5. Systolic blood pressure &gt; 135 mmHg. diastolic &gt; 85 mmHg -

        Exclusion Criteria:

          1. post-menopausal women with less than 12 months from the last menstruation

          2. less than 3 criteria according with ATP III

          3. TSH &gt; 3.5

          4. in treatment with drugs lowering glycemia or cholesterol

          5. allergy to cocoa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosario D'Anna, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Messina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Messina</city>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2011</study_first_submitted>
  <study_first_submitted_qc>July 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2011</study_first_posted>
  <last_update_submitted>July 15, 2013</last_update_submitted>
  <last_update_submitted_qc>July 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Rosario D'anna</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>menopause</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>myo-inositol</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>cocoa polyphenols</keyword>
  <keyword>isoflavones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

